4//SEC Filing
Freddo James L 4
Accession 0001209191-11-004658
CIK 0001128495other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 5:15 PM ET
Size
6.0 KB
Accession
0001209191-11-004658
Insider Transaction Report
Form 4
Freddo James L
SVP, Drug Development and CMO
Transactions
- Award
Stock Option (Right to Buy)
2011-01-20+50,000→ 50,000 totalExercise: $1.29From: 2012-01-20Exp: 2021-01-19→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]50% of the shares subject to the option will become exercisable on January 20, 2012 with the remaining shares subject to the option vesting in equal monthly installments evenly over the next year such that all shares subject to the option will be fully vested and exercisable as of January 20, 2013.
Documents
Issuer
ANADYS PHARMACEUTICALS INC
CIK 0001128495
Entity typeother
Related Parties
1- filerCIK 0001368924
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 5:15 PM ET
- Size
- 6.0 KB